Recent Updates
Recently added Catalysts
NMTC Positive Sentiment Score: 70/100

NeuroOne to Report Second Quarter Fiscal Year 2023 Financial Results and Provide a Corporate Update on May 11

Thursday, May 11, 2023 1 min read
Key Takeaway: NeuroOne Medical Technologies Corporation will report its financial results for the second quarter of fiscal year 2023 on May 11, 2023. The announcement includes a conference call to discuss these results and provide a corporate update. The company is dedicated to developing minimally invasive technologies for various neurological disorders, aiming to enhance patient care and reduce costs associated with surgical procedures. NeuroOne is also exploring applications in additional medical fields, such as mood disorders and artificial intelligence.

Market Sentiment Analysis

POSITIVE FACTORS

  • NeuroOne is focused on improving surgical care options for neurological disorders.
  • The company's technology aims to reduce procedural costs and improve patient outcomes.
  • NeuroOne has broad application potential, including areas like depression and pain management.

Full Press Release Details

EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, will host a conference call to discuss financial results for its fiscal second quarter 2023 ended March 31, 2023 and provide a corporate update on May 11, 2023 at 4:30 PM Eastern Time.
Conference Call and Webcast Information:
Thursday, May 11, 2023 – 4:30 PM Eastern Time
Participant Dial-In:
888-645-4404 / 862-298-0702
877-660-6853 / 201-612-7415, Access ID: 13738525; available through May 25, 2023
Available for 12 months
NeuroOne Medical Technologies Corporation is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com.

Tags

Second Quarter Fiscal Year
medical technology company
surgical care options
neurological disorders

Frequently Asked Questions

When will NeuroOne host its conference call?

NeuroOne's conference call is scheduled for May 11, 2023, at 4:30 PM ET.

What is NeuroOne focused on improving?

NeuroOne aims to enhance surgical care options for patients with neurological disorders.

What types of solutions does NeuroOne provide?

NeuroOne offers minimally invasive and hi-definition solutions for EEG and brain stimulation.

What disorders does NeuroOne target?

NeuroOne targets epilepsy, Parkinson's disease, chronic pain, and more.

What is the access ID for the conference call?

The access ID for the call is 13738525, valid through May 25, 2023.

Tags: NMTC Viatris Investor Conferences Healthcare NeuroOne neurological disorders surgical care medical technology
Last updated: May 11, 2023